Incidence of Pneumocystis jirovecii pneumonia (PJP) in patients receiving BTK inhibitors who did not receive PJP prophylaxis

Leuk Lymphoma. 2022 Aug;63(8):2016-2018. doi: 10.1080/10428194.2022.2056179. Epub 2022 Mar 27.

Authors

James A Davis¹, Anastasia Graham², Lindsey Hendrickson³, Brian Hess³, Kelly Gaffney²

Affiliations

¹ Clinical Pharmacy, MUSC College of Pharmacy, MUSC Hollings Cancer Center, Charleston, SC, USA.
² Clinical Pharmacy, MUSC College of Pharmacy, MUSC Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
³ Division of Hematology/Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.

PMID: 35341452
DOI: 10.1080/10428194.2022.2056179

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunocompromised Host
Incidence
Pneumocystis carinii*
Pneumonia, Pneumocystis* / epidemiology
Pneumonia, Pneumocystis* / etiology
Pneumonia, Pneumocystis* / prevention & control